Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Galli GG"'
Autor:
Barozzi I; Center for Cancer Research, Medical University of Vienna, Vienna, Austria., Slaven N; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley, California., Canale E; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Lopes R; Disease area Oncology, Novartis Biomedical Research, Basel, Switzerland., Amorim Monteiro Barbosa I; Disease area Oncology, Novartis Biomedical Research, Basel, Switzerland., Bleu M; Disease area Oncology, Novartis Biomedical Research, Basel, Switzerland., Ivanoiu D; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Pacini C; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Mensa' E; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Chambers A; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Bravaccini S; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Faculty of Medicine and Surgery, 'Kore' University of Enna, Enna, Italy., Ravaioli S; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Győrffy B; Department of Bioinformatics, Semmelweis University, Budapest, Hungary.; Department of Biophysics, Medical School, University of Pecs, Pecs, Hungary.; Cancer Biomarker Research Group, Institute of Molecular Life Sciences, Research Centre for Natural Sciences, Budapest, Hungary., Dieci MV; Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy., Pruneri G; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Galli GG; Disease area Oncology, Novartis Biomedical Research, Basel, Switzerland., Magnani L; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer, Research, London, United Kingdom.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Sep 04; Vol. 14 (9), pp. 1612-1630.
Autor:
Chapeau EA; Novartis BioMedical Research, Basel, Switzerland. emilie.chapeau@novartis.com., Sansregret L; Novartis BioMedical Research, Basel, Switzerland., Galli GG; Novartis BioMedical Research, Basel, Switzerland., Chène P; Novartis BioMedical Research, Basel, Switzerland., Wartmann M; Novartis BioMedical Research, Basel, Switzerland., Mourikis TP; Novartis BioMedical Research, Basel, Switzerland., Jaaks P; Novartis BioMedical Research, Basel, Switzerland., Baltschukat S; Novartis BioMedical Research, Basel, Switzerland., Barbosa IAM; Novartis BioMedical Research, Basel, Switzerland., Bauer D; Novartis BioMedical Research, Basel, Switzerland., Brachmann SM; Novartis BioMedical Research, Basel, Switzerland., Delaunay C; Novartis BioMedical Research, Basel, Switzerland., Estadieu C; Novartis BioMedical Research, Basel, Switzerland., Faris JE; Novartis BioMedical Research, Cambridge, MA, USA., Furet P; Novartis BioMedical Research, Basel, Switzerland., Harlfinger S; Novartis BioMedical Research, Basel, Switzerland.; AstraZeneca, Oncology R&D, Cambridge, UK., Hueber A; Novartis BioMedical Research, Basel, Switzerland., Jiménez Núñez E; Novartis BioMedical Research, Basel, Switzerland., Kodack DP; Novartis BioMedical Research, Cambridge, MA, USA., Mandon E; Novartis BioMedical Research, Basel, Switzerland., Martin T; Novartis BioMedical Research, Basel, Switzerland., Mesrouze Y; Novartis BioMedical Research, Basel, Switzerland., Romanet V; Novartis BioMedical Research, Basel, Switzerland., Scheufler C; Novartis BioMedical Research, Basel, Switzerland., Sellner H; Novartis BioMedical Research, Basel, Switzerland., Stamm C; Novartis BioMedical Research, Basel, Switzerland., Sterker D; Novartis BioMedical Research, Basel, Switzerland., Tordella L; Novartis BioMedical Research, Basel, Switzerland., Hofmann F; Novartis BioMedical Research, Basel, Switzerland.; Pierre Fabre Group, R&D Medical Care, Toulouse, France., Soldermann N; Novartis BioMedical Research, Basel, Switzerland., Schmelzle T; Novartis BioMedical Research, Basel, Switzerland. tobias.schmelzle@novartis.com.
Publikováno v:
Nature cancer [Nat Cancer] 2024 Jul; Vol. 5 (7), pp. 1130.
Autor:
Mermet-Meillon F; Disease Area Oncology, Novartis Biomedical Research, Basel, Switzerland., Mercan S; Disease Area Oncology, Novartis Biomedical Research, Basel, Switzerland., Bauer-Probst B; Disease Area Oncology, Novartis Biomedical Research, Basel, Switzerland., Allard C; Disease Area Immunology, Novartis Biomedical Research, Basel, Switzerland., Bleu M; Disease Area Oncology, Novartis Biomedical Research, Basel, Switzerland., Calkins K; Disease Area Oncology, Novartis Biomedical Research, Basel, Switzerland., Knehr J; Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland., Altorfer M; Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland., Naumann U; Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland., Sprouffske K; Disease Area Oncology, Novartis Biomedical Research, Basel, Switzerland., Barys L; Disease Area Oncology, Novartis Biomedical Research, Basel, Switzerland., Sesterhenn F; Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland. fabian.sesterhenn@novartis.com., Galli GG; Disease Area Oncology, Novartis Biomedical Research, Basel, Switzerland. giorgio.galli@novartis.com.
Publikováno v:
Nature structural & molecular biology [Nat Struct Mol Biol] 2024 Jul; Vol. 31 (7), pp. 1018-1022. Date of Electronic Publication: 2024 Feb 12.
Autor:
Chapeau EA; Novartis BioMedical Research, Basel, Switzerland. emilie.chapeau@novartis.com., Sansregret L; Novartis BioMedical Research, Basel, Switzerland., Galli GG; Novartis BioMedical Research, Basel, Switzerland., Chène P; Novartis BioMedical Research, Basel, Switzerland., Wartmann M; Novartis BioMedical Research, Basel, Switzerland., Mourikis TP; Novartis BioMedical Research, Basel, Switzerland., Jaaks P; Novartis BioMedical Research, Basel, Switzerland., Baltschukat S; Novartis BioMedical Research, Basel, Switzerland., Barbosa IAM; Novartis BioMedical Research, Basel, Switzerland., Bauer D; Novartis BioMedical Research, Basel, Switzerland., Brachmann SM; Novartis BioMedical Research, Basel, Switzerland., Delaunay C; Novartis BioMedical Research, Basel, Switzerland., Estadieu C; Novartis BioMedical Research, Basel, Switzerland., Faris JE; Novartis BioMedical Research, Cambridge, MA, USA., Furet P; Novartis BioMedical Research, Basel, Switzerland., Harlfinger S; Novartis BioMedical Research, Basel, Switzerland.; AstraZeneca, Oncology R&D, Cambridge, UK., Hueber A; Novartis BioMedical Research, Basel, Switzerland., Jiménez Núñez E; Novartis BioMedical Research, Basel, Switzerland., Kodack DP; Novartis BioMedical Research, Cambridge, MA, USA., Mandon E; Novartis BioMedical Research, Basel, Switzerland., Martin T; Novartis BioMedical Research, Basel, Switzerland., Mesrouze Y; Novartis BioMedical Research, Basel, Switzerland., Romanet V; Novartis BioMedical Research, Basel, Switzerland., Scheufler C; Novartis BioMedical Research, Basel, Switzerland., Sellner H; Novartis BioMedical Research, Basel, Switzerland., Stamm C; Novartis BioMedical Research, Basel, Switzerland., Sterker D; Novartis BioMedical Research, Basel, Switzerland., Tordella L; Novartis BioMedical Research, Basel, Switzerland., Hofmann F; Novartis BioMedical Research, Basel, Switzerland.; Pierre Fabre Group, R&D Medical Care, Toulouse, France., Soldermann N; Novartis BioMedical Research, Basel, Switzerland., Schmelzle T; Novartis BioMedical Research, Basel, Switzerland. tobias.schmelzle@novartis.com.
Publikováno v:
Nature cancer [Nat Cancer] 2024 Jul; Vol. 5 (7), pp. 1102-1120. Date of Electronic Publication: 2024 Apr 02.
Autor:
Cremosnik GS; Global Discovery Chemistry, Novartis Biomedical Research, CH-4056 Basel, Switzerland., Mesrouze Y; Disease area Oncology, Novartis Biomedical Research, CH-4056 Basel, Switzerland., Zueger P; Global Discovery Chemistry, Novartis Biomedical Research, CH-4056 Basel, Switzerland., Furkert D; Discovery Sciences, Novartis Biomedical Research, CH-4056 Basel, Switzerland., Grandjean F; Discovery Sciences, Novartis Biomedical Research, CH-4056 Basel, Switzerland., Argoti D; Global Discovery Chemistry, Novartis Biomedical Research, Emeryville, California 94608, United States., Mermet-Meillon F; Disease area Oncology, Novartis Biomedical Research, CH-4056 Basel, Switzerland., Bauer MR; Global Discovery Chemistry, Novartis Biomedical Research, CH-4056 Basel, Switzerland., Brittain S; Discovery Sciences, Novartis Biomedical Research, Cambridge, Massachusetts 02139, United States., Rogemoser P; Discovery Sciences, Novartis Biomedical Research, Cambridge, Massachusetts 02139, United States., Yang W; Discovery Sciences, Novartis Biomedical Research, Cambridge, Massachusetts 02139, United States., Giovannoni J; Discovery Sciences, Novartis Biomedical Research, CH-4056 Basel, Switzerland., McGregor L; Discovery Sciences, Novartis Biomedical Research, Cambridge, Massachusetts 02139, United States., Tang J; Global Discovery Chemistry, Novartis Biomedical Research, Emeryville, California 94608, United States., Knapp M; Global Discovery Chemistry, Novartis Biomedical Research, Emeryville, California 94608, United States., Holzinger S; Discovery Sciences, Novartis Biomedical Research, CH-4056 Basel, Switzerland., Buhr S; Discovery Sciences, Novartis Biomedical Research, CH-4056 Basel, Switzerland., Muller L; Discovery Sciences, Novartis Biomedical Research, CH-4056 Basel, Switzerland., Leder L; Discovery Sciences, Novartis Biomedical Research, CH-4056 Basel, Switzerland., Xie L; Discovery Sciences, Novartis Biomedical Research, Emeryville, California 94608, United States., Fernandez C; Discovery Sciences, Novartis Biomedical Research, CH-4056 Basel, Switzerland., Nieto-Oberhuber C; Global Discovery Chemistry, Novartis Biomedical Research, CH-4056 Basel, Switzerland., Chène P; Disease area Oncology, Novartis Biomedical Research, CH-4056 Basel, Switzerland., Galli GG; Disease area Oncology, Novartis Biomedical Research, CH-4056 Basel, Switzerland., Sesterhenn F; Discovery Sciences, Novartis Biomedical Research, CH-4056 Basel, Switzerland.
Publikováno v:
ACS chemical biology [ACS Chem Biol] 2024 May 17; Vol. 19 (5), pp. 1142-1150. Date of Electronic Publication: 2024 Apr 24.
Autor:
Barbosa IAM; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Gopalakrishnan R; Disease Area Oncology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Alltrna Inc., One Kendall Square, Cambridge, MA, USA., Mercan S; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Mourikis TP; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Martin T; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Wengert S; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland.; Helmholtz Pioneer Campus, Helmholtz Zentrum München GmbH German Research Center for Environmental Health, Neuherberg, Germany., Sheng C; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Ji F; Disease Area Oncology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Lopes R; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland.; Roche Pharmaceutical Research and Early Development, Basel, Switzerland., Knehr J; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Altorfer M; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Lindeman A; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Russ C; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Naumann U; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Golji J; Disease Area Oncology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Sprouffske K; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Barys L; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Tordella L; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Schübeler D; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Faculty of Sciences, University of Basel, Basel, Switzerland., Schmelzle T; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Galli GG; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland. giorgio.galli@novartis.com.
Publikováno v:
Nature communications [Nat Commun] 2023 Jul 03; Vol. 14 (1), pp. 3907. Date of Electronic Publication: 2023 Jul 03.
Autor:
Hauseman ZJ; Novartis Institutes for BioMedical Research, Cambridge, MA, USA. zachary.hauseman@novartis.com., Fodor M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Dhembi A; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Viscomi J; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Egli D; Novartis Institutes for BioMedical Research, Basel, Switzerland., Bleu M; Novartis Institutes for BioMedical Research, Basel, Switzerland., Katz S; Novartis Institutes for BioMedical Research, Basel, Switzerland., Park E; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Jang DM; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Porter KA; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Meili F; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Guo H; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Kerr G; Novartis Institutes for BioMedical Research, Basel, Switzerland., Mollé S; Novartis Institutes for BioMedical Research, Basel, Switzerland., Velez-Vega C; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Beyer KS; Novartis Institutes for BioMedical Research, Basel, Switzerland., Galli GG; Novartis Institutes for BioMedical Research, Basel, Switzerland., Maira SM; Novartis Institutes for BioMedical Research, Basel, Switzerland., Stams T; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Clark K; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Eck MJ; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Tordella L; Novartis Institutes for BioMedical Research, Basel, Switzerland. luca.tordella@novartis.com., Thoma CR; Novartis Institutes for BioMedical Research, Cambridge, MA, USA. claudio.thoma@novartis.com., King DA; Novartis Institutes for BioMedical Research, Cambridge, MA, USA. dan.king@novartis.com.
Publikováno v:
Nature [Nature] 2022 Sep; Vol. 609 (7926), pp. 416-423. Date of Electronic Publication: 2022 Jul 13.
Autor:
Vulin M; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Jehanno C; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland., Sethi A; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Swiss Institute of Bioinformatics, Basel, Switzerland., Correia AL; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Obradović MMS; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Couto JP; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Coissieux MM; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Diepenbruck M; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland., Preca BT; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland., Volkmann K; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland., der Maur PA; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland., Schmidt A; Proteomics Core Facility, Biozentrum, University of Basel, Basel, Switzerland., Münst S; Institute of Pathology and Medical Genetics, University Hospital Basel, University of Basel, Basel, Switzerland., Sauteur L; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland., Kloc M; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Swiss Institute of Bioinformatics, Basel, Switzerland., Palafox M; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland., Britschgi A; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Unterreiner V; Novartis Institutes for Biomedical Research, Basel, Switzerland., Galuba O; Novartis Institutes for Biomedical Research, Basel, Switzerland., Claerr I; Novartis Institutes for Biomedical Research, Basel, Switzerland., Lopez-Romero S; Novartis Institutes for Biomedical Research, Basel, Switzerland., Galli GG; Novartis Institutes for Biomedical Research, Basel, Switzerland., Baeschlin D; Novartis Institutes for Biomedical Research, Basel, Switzerland., Okamoto R; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Soysal SD; Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Breast Cancer Center, University Hospital Basel, University of Basel, Basel, Switzerland., Mechera R; Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Breast Cancer Center, University Hospital Basel, University of Basel, Basel, Switzerland., Weber WP; Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Breast Cancer Center, University Hospital Basel, University of Basel, Basel, Switzerland., Radimerski T; Novartis Institutes for Biomedical Research, Basel, Switzerland., Bentires-Alj M; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland. m.bentires-alj@unibas.ch.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. m.bentires-alj@unibas.ch.
Publikováno v:
Oncogene [Oncogene] 2022 Sep; Vol. 41 (39), pp. 4459-4473. Date of Electronic Publication: 2022 Aug 25.
Autor:
Lee E; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Szvetecz S; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Polli R; PKS Oncology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Grauel A; Immuno-Oncology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Chen J; PCS Toxicology, Novartis Institutes for Biomedical Research, East Hanover, NJ, USA., Judge J; PCS Toxicology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Jaiswal S; PCS Toxicology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Maeda R; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Schwartz S; Immuno-Oncology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Voedisch B; NIBR Biologics Center, Novartis Institutes for Biomedical Research, Basel, Switzerland., Piksa M; NIBR Biologics Center, Novartis Institutes for Biomedical Research, Basel, Switzerland., Japutra C; NIBR Biologics Center, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Sadhasivam L; NIBR Biologics Center, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Wang Y; NIBR Biologics Center, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Carrion A; NIBR Biologics Center, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Isim S; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Liang J; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Nicholson T; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Lei H; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Fang Q; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Steinkrauss M; PCS Toxicology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Walker D; PCS Toxicology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Wagner J; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Cremasco V; Immuno-Oncology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Wang HQ; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Galli GG; Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Granda B; NIBR Biologics Center, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Mansfield K; PCS Toxicology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Simmons Q; PCS Toxicology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Nguyen AA; NIBR Biologics Center, Novartis Institutes for Biomedical Research, Cambridge, MA, USA. anh.nguyen@novartis.com., Vincent Jordan N; Novartis Institutes for Biomedical Research, Cambridge, MA, USA. nicole.vincentjordan@gmail.com.
Publikováno v:
Scientific reports [Sci Rep] 2021 Jul 21; Vol. 11 (1), pp. 14841. Date of Electronic Publication: 2021 Jul 21.
Autor:
Lopes R; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland. rui.lopes@novartis.com giorgio.galli@novartis.com., Sprouffske K; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland., Sheng C; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland., Uijttewaal ECH; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland., Wesdorp AE; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland., Dahinden J; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland., Wengert S; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland., Diaz-Miyar J; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland., Yildiz U; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland., Bleu M; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland., Apfel V; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland., Mermet-Meillon F; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland., Krese R; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland., Eder M; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland., Olsen AV; Biotech Research and Innovation Centre (BRIC), The Finsen Laboratory, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Hoppe P; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Knehr J; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Carbone W; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Cuttat R; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Waldt A; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Altorfer M; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Naumann U; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Weischenfeldt J; Biotech Research and Innovation Centre (BRIC), The Finsen Laboratory, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., deWeck A; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland., Kauffmann A; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland., Roma G; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Schübeler D; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Faculty of Sciences, University of Basel, Basel, Switzerland., Galli GG; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland. rui.lopes@novartis.com giorgio.galli@novartis.com.
Publikováno v:
Science advances [Sci Adv] 2021 Jul 02; Vol. 7 (27). Date of Electronic Publication: 2021 Jul 02 (Print Publication: 2021).